The Adipose Tissue at the Crosstalk Between EDCs and Cancer Development
Emma Bokobza(Inserm), Nicolas Chevalier(Inserm), Victor Tiroille(Inserm), Frédéric Bost(Inserm), Stéphan Clavel(Centre Intégré de Santé et de Services Sociaux des Laurentides), Charlotte Hinault(Inserm)
Cited by 35
Related Papers
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
|Oncogene|2008|852
Human Health and Ocean Pollution
|Annals of Global Health|2020|751
Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
|Cancer Research|2011|620
Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
|Cancer Research|2010|528
Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?
|Molecular Cancer Therapeutics|2010|490